Piramal Pharma Ltd
Please refer attachment.
Piramal Pharma Ltd has informed that its commercial arrangement with Bayer Pharmaceuticals Private Limited will expire on 31st December, 2026, and will not be renewed. The arrangement accounted for less than 5% of the company's consolidated revenue and is commission-based, with no material impact expected on profitability or financial position.